Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic sclerosis.

S C Ng1

  • 1Department of Medicine, Alexandra Hospital, Singapore.

Singapore Medical Journal
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Systemic Sclerosis is a multisystemic autoimmune disease affecting skin and organs. While no cure exists, management focuses on improving quality of life through symptom control and supportive care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut microbiota in the pathogenesis of COVID-19: viral replication and transmission (abridged secondary publication).

Hong Kong medical journal = Xianggang yi xue za zhi·2025
Same author

Diet outperforms microbial transplant to drive microbiome recovery in mice.

Nature·2025
Same author

Iron burden and endocrine complications in transfusion-dependent thalassemia patients In Sarawak, Malaysia: a retrospective study.

The Medical journal of Malaysia·2024
Same author

<math></math> La<sub>max</sub>: determining the optimal test duration for maximal lactate formation rate during all-out sprint cycle ergometry.

European journal of applied physiology·2024
Same author

Faecal microbiota transplantation for patients with irritable bowel syndrome: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same author

Dietary habits and physical activity during the third wave of the COVID-19 pandemic: associated factors, composite outcomes in a cross-sectional telephone survey of a Chinese population, and trend analysis.

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same journal

Response to comments on: Diagnostic classification of dermatomyositis with and without electrodiagnostic study: real-world clinical practice.

Singapore medical journal·2026
Same journal

Comments on: Diagnostic classification of dermatomyositis with and without electrodiagnostic study: real-world clinical practice.

Singapore medical journal·2026
Same journal

Computed tomographic evaluation of bronchiolitis: unravelling the multifaceted spectrum of airways and pulmonary abnormalities.

Singapore medical journal·2026
Same journal

Approach to facial pain.

Singapore medical journal·2026
Same journal

Glioblastoma: current challenges and future horizons.

Singapore medical journal·2026
Same journal

The role of public health specialists in tertiary hospitals in Singapore.

Singapore medical journal·2026
See all related articles

Area of Science:

  • Rheumatology
  • Immunology
  • Dermatology

Background:

  • Systemic Sclerosis (SSc) is a complex autoimmune condition.
  • Characterized by skin and visceral organ sclerosis, vasculopathy (Raynaud's phenomenon), and autoantibodies.
  • Classified into diffuse, limited (CREST syndrome), and overlap variants, with localized forms also existing.

Purpose of the Study:

  • To provide an overview of Systemic Sclerosis.
  • To outline diagnostic criteria and presenting features.
  • To discuss current management strategies and emerging treatments.

Main Methods:

  • Review of diagnostic criteria for Systemic Sclerosis.
  • Description of common clinical manifestations and organ involvement.
  • Summary of therapeutic approaches, including supportive care and disease-modifying drugs.

Related Experiment Videos

Main Results:

  • Systemic Sclerosis diagnosis relies on major (proximal scleroderma) or minor criteria (sclerodactyly, digital scars, pulmonary fibrosis).
  • Presenting symptoms include Raynaud's phenomenon, skin changes, arthralgia, and potential organ-specific complaints.
  • Management involves patient education, skin care, exercise, and pharmacotherapy for complications.

Conclusions:

  • Effective management of Systemic Sclerosis improves patient quality of life.
  • Pharmacological interventions target symptoms like Raynaud's phenomenon and organ complications.
  • Ongoing research explores disease-modifying drugs, with ketotifen showing promise.